• / Free eNewsletters & Magazine
  • / My Account
Home>Finance>Technology>Biotechnology

Biotechnology

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  6. Research
  1. 3D Bioprinting Pioneers RBCC and n3D Biosciences Network With Top Biotechnology Investors This Week at Biotech Showcase 2015 in San Francisco

    3D Bioprinting Pioneers RBCC and n3D Biosciences Network With Top Biotechnology Investors This Week at Biotech Showcase 2015 in San Francisco

  2. 17th Annual BIO CEO & Investor Conference to Feature Congressional Leaders, Institutional Investors, Industry Analysts and Senior Biotechnology Executives

    17th Annual BIO CEO & Investor Conference to Feature Congressional Leaders, Institutional Investors, Industry Analysts and Senior Biotechnology Executives

  3. Research and Markets: Protein Kinase Inhibitors in Oncology Drug Pipeline Update 2015 - 341 Companies Plus Partners Developing 590 PKI Drugs in 2360 Developmental Projects

    Research and Markets: Protein Kinase Inhibitors in Oncology Drug Pipeline Update 2015 - 341 Companies Plus Partners Developing 590 PKI Drugs in 2360 Developmental Projects

  4. Surgeon, Dr. Jeffrey H. Lawson, to Present on Bioengineering and the Potential to Create New Blood Vessels at the International Symposium for Endovascular Therapy

    Surgeon, Dr. Jeffrey H. Lawson, to Present on Bioengineering and the Potential to Create New Blood Vessels at the International Symposium for Endovascular Therapy

  5. Microsoft Ventures Accelerator Jump Starts the Development of 100 Startups in China

    Microsoft Ventures Accelerator Jump Starts the Development of 100 Startups in China

  6. Opsona Therapeutics Ltd. Initiates a Prospective Open Label Phase I/II Study in Second-Line Lower (Low and Intermediate-1) Risk Myelodysplastic Syndrome (MDS) with OPN-305, a First-in Class ...

    Opsona Therapeutics Ltd. Initiates a Prospective Open Label Phase I/II Study in Second-Line Lower (Low and Intermediate-1) Risk Myelodysplastic Syndrome (MDS) with OPN-305, a First-in Class Monoclonal Antibody That Blocks Toll-Like Receptor 2

  7. Roche receives FDA clearance for next generation cobas MRSA/SA Test

    Roche receives FDA clearance for next generation cobas MRSA/SA Test

  8. Puma Biotechnology Announces Proposed Public Offering

    Puma Biotechnology Announces Proposed Public Offering

  9. Roche to Acquire France-Based Biotech Company

    Roche to Acquire France-Based Biotech Company

  10. Roche to Acquire France-Based Biotech Company

    Roche to Acquire France-Based Biotech Company

12345
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.